---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-002038"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2022-02-01T23:59:59+00:00"
generated_at: "2026-06-27T13:16:11.561678+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne Q2 FY2022: GAAP EPS $1.94, adj EPS $1.88; rev $269.3M; $0.32 dividend, $400M buyback

## Summary
- Organic revenue +17% to $269.3M; Protein Sciences organic growth 19% with ProteinSimple up 27% and GMP Proteins >180%.
- GAAP EPS $1.94 vs $1.15 YoY; record adjusted EPS $1.88 vs $1.62 YoY.
- Adjusted operating income $102.8M, margin 38.3%; up 18% YoY.
- Board declared $0.32 quarterly dividend, payable Feb 25, 2022 to holders of record Feb 11, 2022.
- New $400M share repurchase program approved, replacing prior program, effective Feb 2, 2022.

## SEC filing metadata
- accession: 0001437749-22-002038
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2022-02-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000143774922002038/0001437749-22-002038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000143774922002038/tech20220131_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-002038
- JSON: https://secwatch.observer/filing/0001437749-22-002038.json
- Plain text: https://secwatch.observer/filing/0001437749-22-002038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.